Personalized clinical managements through exploring circulating neural cells and electroencephalography

Table 2 Erythroblastosis virus E26 oncogene homolog 2 protein expressions status in healthy individuals as control for the patients with Alzheimer disease

ID	Age, yr	Ets2 protein expression (%)	Total cells analyzed
C-1	65	2 (0.066)	3025
C-2	56	10 (0.19)	5214
C-3	79	0 (0)	1546
C-4	74	3 (0.065)	4587
C-5	79	6 (0.48)	1232
C-6	62	3 (0.38)	783
C-7	42	0 (0)	923
C-8	54	4 (0.10)	9823
C-9	81	7 (004)	874
C-10	79	3 (0.19)	1542
Total		38 (0.12)	29549

The cells were analysed by flow cytometry: All controls (C) had no family history of Alzheimer disease. C: Control; Ets2: Erythroblastosis virus E26 oncogene homolog 2.